about
Gene delivery technologies for cardiac applicationsAdeno-associated virus-mediated gene therapy in cardiovascular diseaseTargeting S100A1 in heart failureMolecular targets in heart failure gene therapy: current controversies and translational perspectivesAnti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockadeThe natural history of acute dilated cardiomyopathy.High-throughput FRET assay yields allosteric SERCA activatorsA novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum.A parallel wire robot for epicardial interventions.AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Ophiopogonin D maintains Ca2+ homeostasis in rat cardiomyocytes in vitro by upregulating CYP2J3/EETs and suppressing ER stress.The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferationPotential of gene therapy as a treatment for heart failureParallel Force/Position Control of an Epicardial Parallel Wire Robot.Calcium cycling proteins and their association with heart failure.Contemporary management and research directions in advanced heart failure: where are we going?Synthetic biology with surgical precision: targeted reengineering of signaling proteins.Sarcoplasmic reticulum and calcium cycling targeting by gene therapy.Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.Regenerating cardiac cells: insights from the bench and the clinic.Gene therapy for heart failure: where do we stand?Molecular targets of current and prospective heart failure therapies.Genetics of cerebral vasospasm.Therapeutic potential of genes in cardiac repair.Efficient nonviral gene therapy with FasL and Del1 fragments in mice.Cardiac AAV9 Gene Delivery Strategies in Adult Canines: Assessment by Long-term Serial SPECT Imaging of Sodium Iodide Symporter Expression.Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a".Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.Translational medicine: to the rescue of the failing heart.Non-invasive detection of adeno-associated viral gene transfer using a genetically encoded CEST-MRI reporter gene in the murine heart.Using Acellular Bioactive Extracellular Matrix Scaffolds to Enhance Endogenous Cardiac Repair.
P2860
Q26863362-AC24555A-068E-454B-A9C4-120EADB4EF6DQ28081681-4F2BBD43-BA99-4A1C-8259-C10DA0B824DAQ28259868-C2C59966-B063-4F9E-8C03-6B18A36DC508Q28265749-00342AC3-16F8-4FEA-877C-D733C91E8270Q28535743-2F4DE078-6316-4264-B105-2986E873BB7AQ33957691-2A2908C0-B1CB-4854-87D6-1574EAEE207DQ34393960-83ECB406-E0F7-484B-B30B-DB6F40DCA9D3Q35132004-FB69585D-9398-45AC-90AD-5F4D7C90C102Q35178257-DC2DDC49-2C63-40ED-962C-8405C8737186Q35238264-12A19744-FB06-42E7-94AE-61FB4BC4F623Q35912519-4964F5E5-F8B1-4C13-9F44-614ADBA13428Q36042588-AF643F7B-E049-4A0F-8731-4D2011211634Q36497159-58720162-2E3D-40E7-AF7E-68DCAB0FEF59Q36992680-9A3A856C-DFEE-4705-9C3E-E8E49F680985Q37915240-FB8F03FC-21A0-4C31-9CA3-537E30BF751EQ37929868-E80F3746-40E1-4E2B-94DB-68B9655A997FQ38016028-A32B3270-13EE-4953-998D-B98896A4C8CAQ38016716-D5A8A70D-45AE-4F39-9452-0116B497A66BQ38025012-2D0DD24F-68EF-4D21-9C86-8E032CFB0F2CQ38032473-46F8B018-062B-435E-8C61-EC217730A357Q38073152-6FBF285E-4826-4229-945A-C2EDA6C36D08Q38076688-D66E4713-E27D-4E47-8D7E-3ECC95236114Q38108312-905A8467-5153-43E6-954A-A4D56C292A66Q38128924-4B4D6562-026C-48A8-B962-D91657FBC3DAQ39247938-F5A12C3E-F8BB-481B-A72F-7BF226F4DBA8Q39787354-5AB1EDAB-A86B-41C4-BE99-D5259FA0D51BQ44084499-15671376-7782-4162-90DB-423FEF6852D0Q45886178-8F257D17-9EA8-4A89-8968-A1EBB6D0C62EQ46121922-EA701CC2-D1B7-42FF-AE50-97255E44CE64Q51762700-9A8BC593-B809-455C-80E2-94B7753E0A57Q55118363-635E51C1-F73E-436A-B876-C9614149040F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rescuing the failing heart by targeted gene transfer
@ast
Rescuing the failing heart by targeted gene transfer
@en
Rescuing the failing heart by targeted gene transfer
@nl
type
label
Rescuing the failing heart by targeted gene transfer
@ast
Rescuing the failing heart by targeted gene transfer
@en
Rescuing the failing heart by targeted gene transfer
@nl
prefLabel
Rescuing the failing heart by targeted gene transfer
@ast
Rescuing the failing heart by targeted gene transfer
@en
Rescuing the failing heart by targeted gene transfer
@nl
P2093
P2860
P1476
Rescuing the failing heart by targeted gene transfer
@en
P2093
Dennis Ladage
Roger J Hajjar
Yoshiaki Kawase
P2860
P304
P356
10.1016/J.JACC.2010.11.023
P407
P577
2011-03-01T00:00:00Z